Keywords: Takeda, Russia, BRIC market, Expansion, Nycomed

Takeda Pharma considering expansion in Russia and other BRIC countries

Article | 25 October 2012

Print This

Amid the falling dynamics in the European Union and the USA, Japan’s largest drugmaker Takeda Pharmaceutical (TYO: 4502) is ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in